Literature DB >> 17996990

HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and meta-analysis.

G La Torre1, C de Waure, G Chiaradia, A Mannocci, W Ricciardi.   

Abstract

INTRODUCTION: We performed a pooled analysis of randomised clinical trials (RCT) on HPV vaccine efficacy in preventing cervical persistent infection.
METHODS: We carried out a bibliographic search on electronic databases and we selected RCT to perform the meta-analyses.
RESULTS: We selected five studies. The first meta-analysis, including all studies, showed an important reduction of the risk of infection from HPV 16 in vaccinated cohort [RR 0.10 (95% CI: 0.07-0.15)]. The second and third meta-analyses, including only studies on bivalent and tetravalent vaccines, showed a RR of 0.13 (95% CI: 0.09-0.20) for HPV 16 infections and a RR of 0.22 (95% CI: 0.13-0.38) for HPV 18 ones. DISCUSSION: HPV vaccine efficacy in preventing persistent infection is high but there is the need for further studies on the duration of immunization and long-term vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996990     DOI: 10.1016/j.vaccine.2007.09.027

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  Economic evaluation of human papilloma virus vaccination in the European Union: a critical review.

Authors:  Daniela Koleva; Paola De Compadri; Anna Padula; Livio Garattini
Journal:  Intern Emerg Med       Date:  2011-02-11       Impact factor: 3.397

2.  Knowledge levels of adolescent girls about human papilloma virus and its vaccine.

Authors:  Orkun Çetin; Fatma Ferda Verit; Seda Keskin; Ali Galip Zebitay; Ayşegül Deregözü; Taner Usta; Oğuz Yücel
Journal:  Turk Pediatri Ars       Date:  2014-06-01

3.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

4.  Young women's constructions of the HPV vaccine: a cross-cultural, qualitative study in Scotland, Spain, Serbia and Bulgaria.

Authors:  Carol Gray Brunton; Ingeborg Farver; Moritz Jäger; Anita Lenneis; Kadi Parve; Dina Patarcic; Dafina Petrova; Rhona Hogg; Catriona Kennedy; Rocio Garcia-Retamero; Irina Todorova
Journal:  Int J Behav Med       Date:  2014-02

5.  Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.

Authors:  Ali Rowhani-Rahbar; Constance Mao; James P Hughes; Frances B Alvarez; Janine T Bryan; Stephen E Hawes; Noel S Weiss; Laura A Koutsky
Journal:  Vaccine       Date:  2009-07-30       Impact factor: 3.641

Review 6.  The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis.

Authors:  Yvonne Deleré; Ole Wichmann; Stefanie J Klug; Marianne van der Sande; Martin Terhardt; Fred Zepp; Thomas Harder
Journal:  Dtsch Arztebl Int       Date:  2014-09-01       Impact factor: 5.594

Review 7.  Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.

Authors:  Beibei Lu; Ambuj Kumar; Xavier Castellsagué; Anna R Giuliano
Journal:  BMC Infect Dis       Date:  2011-01-12       Impact factor: 3.090

8.  HPV catch-up vaccination of young women: a systematic review and meta-analysis.

Authors:  Elisabeth Couto; Ingvil Sæterdal; Lene Kristine Juvet; Marianne Klemp
Journal:  BMC Public Health       Date:  2014-08-23       Impact factor: 3.295

9.  Does the HPV vaccination programme have implications for cervical screening programmes in the UK?

Authors:  Helen Beer; Sam Hibbitts; Sinead Brophy; M A Rahman; Jo Waller; Shantini Paranjothy
Journal:  Vaccine       Date:  2014-02-13       Impact factor: 3.641

10.  HPV infections among MSM in Shenzhen, China.

Authors:  Dong-Yan Zhang; Yue-Ping Yin; Tie-Jian Feng; Fu-Chang Hong; Ning Jiang; Bao-Xi Wang; Xiang-Sheng Chen
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.